Choriocarcinoma is a rare type of cancer that typically develops in the early stages of a woman’s pregnancy. Choriocarcinoma occurs when a malignant mass on the placenta begins to grow on the fetus. This type of cancer is classified as a Gestational Trophoblastic Disease. Sometimes, Choriocarcinoma can stop the development of the fetus. In most cases, Choriocarcinoma develops as a result of hydatidiform mole, a spontaneous abortion, a normal pregnancy or an ectopic pregnancy. Symptoms of Choriocarcinoma include vaginal bleeding, and pain, among others. If Choriocarcinoma is detected early enough, it can most often be treated with chemotherapy. In rare cases, Choriocarcinoma can occur in the testis, ovaries, or cervix.
Choriocarcinoma Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Choriocarcinoma below!
For more information on how to use Laverne, please read the How to Guide.
We have 2913 products for the study of Choriocarcinoma that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.